Chevron to Explore Ways to Use Illumina s Technology | GenomeWeb

NEW YORK, Feb 27 – Illumina of San Diego said Tuesday it had penned a deal with Chevron Research and Technology to study ways Illumina’s fiber-optic BeadArray microarray technology could be used to detect compounds in chemical plant operations.

Chevron, which is funding the study, expects to complete the research by early 2002. Chevron previously invested in Illumina through its venture capital group.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.